Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -57.26x is 83% above its 5-year average of -334.85x, near the high end of its 5-year range (-1668.33x–-11.05x).
11.22% above its 12-month average of -64.50x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -11.80x.
INTEREST COVERAGE RATIO
-57.26x
INTEREST COVERAGE RATIO AVG TTM
-64.50x
INTEREST COVERAGE RATIO AVG 3Y
-122.24x
INTEREST COVERAGE RATIO AVG 5Y
-334.85x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.22%
CURRENT VS 3Y AVG
+53.16%
CURRENT VS 5Y AVG
+82.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
-933.57%
vs the sector median at left
Lifeward Ltd.
Market Cap
$10.60M
Interest Coverage Ratio
-57.26x
TTM Avg
-64.50x
3Y Avg
-122.24x
5Y Avg
-334.85x
Market Cap
$10.42M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.36M
Interest Coverage Ratio
-309.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.94M
Interest Coverage Ratio
-219.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.18M
Interest Coverage Ratio
-12.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.02M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.05M
Interest Coverage Ratio
-129.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifeward Ltd. (LFWD) | $10.60M | -57.26x | -64.50x | -122.24x | -334.85x |
| Polyrizon Ltd. (PLRZ)vs › | $10.64M | -1.99x | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.42M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.82M | -4.24x | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.36M | -309.66x | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.94M | -219.72x | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.18M | -12.65x | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | N/A | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.05M | -129.91x | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.17M | 26.76x | 26.76x | 26.76x | 26.76x |
Interest Coverage
-57.3x
Debt/Equity
0.91
Current Ratio
2.33
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -11.80x |
| 2026-03-31 | -23.08x |
| 2025-12-31 | -11.05x |
| 2025-09-30 | -108.28x |
| 2025-06-30 | -168.28x |
| 2025-03-31 | -156.55x |
| 2024-12-31 | -307.32x |
| 2024-09-30 | -122.08x |
| 2024-06-30 | -116.92x |
| 2024-03-31 | -197.03x |
| 2023-12-31 | -1534.25x |
| 2023-06-30 | -644.75x |
| 2023-03-31 | -546.88x |
| 2022-12-31 | -1668.33x |
| 2022-06-30 | -875.20x |
| 2022-03-31 | -476.44x |
| 2021-12-31 | -766.20x |
| 2021-09-30 | -532.40x |
| 2021-06-30 | -628.20x |
